{
  "id": 28135,
  "title": "Novo setback casts doubt on a new way to treat heart disease",
  "url": "https://urgent.news/2026/07/31/novo-setback-casts-doubt-on-a-new-way-to-treat-heart-disease",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-07-31T16:11:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/novo-nordik-ziltivekimab-zeus-study-results-corvidia/826695/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Ziltivekimab's failure in a key trial spurred share sell-offs for Novo and other biotechs, as it suggested trouble for different cardiovascular drugs that also target inflammation.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}